Literature DB >> 1460329

Ductal adenocarcinoma of the pancreas. Histopathological features and prognosis.

A Tannapfel1, C Wittekind, G Hünefeld.   

Abstract

Between 1972 and 1987, curative surgical resection (RO) was performed in 81 patients with ductal adenocarcinoma of the pancreas. In this study, slides from surgical specimens were reviewed, and histopathological features of the carcinomas were retrospectively reevaluated. Tumor stage was the most important prognostic factor: In UICC stages I, II, and III, the median survival times were 13, 16, and 8 mo, respectively. Lymph node involvement and direct extension of the tumor into adjacent peripancreatic tissue, as well as invasion into peripancreatic organs were found to significantly influence survival. Tumor infiltration of the lymphatic vessels was present in 74% of the resected carcinomas and significantly correlated with survival time. There was no relationship between survival and tumor size; furthermore, histological grade of differentiation, age, and sex had no influence on prognosis.

Entities:  

Mesh:

Year:  1992        PMID: 1460329     DOI: 10.1007/bf02924638

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  34 in total

1.  Survival in 1001 patients with carcinoma of the pancreas.

Authors:  M M Connolly; P J Dawson; F Michelassi; A R Moossa; F Lowenstein
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

2.  Is resection appropriate for adenocarcinoma of the pancreas? A cost-benefit analysis.

Authors:  M S Lea; L H Stahlgren
Journal:  Am J Surg       Date:  1987-12       Impact factor: 2.565

3.  Pancreatic cancer: nihilism is obsolete!

Authors:  H O Douglass
Journal:  Pancreas       Date:  1987       Impact factor: 3.327

Review 4.  [Pancreatic cancer].

Authors:  G Klöppel
Journal:  Verh Dtsch Ges Pathol       Date:  1987

5.  Lymph node involvement in carcinoma of the head of the pancreas area.

Authors:  A L Cubilla; J Fortner; P J Fitzgerald
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

6.  Staging of cancer of the pancreas. Cancer of the Pancreas Task Force.

Authors: 
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

7.  Pancreatic arteriography, transhepatic pancreatic venography, and pancreatic venous sampling in diagnosis of pancreatic cancer.

Authors:  J Rosch; F S Keller
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

8.  Pancreatoduodenectomy for resectable malignant periampullary tumors.

Authors:  J M Kellum; J Clark; H H Miller
Journal:  Surg Gynecol Obstet       Date:  1983-10

9.  Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical cases.

Authors:  T Morohoshi; G Held; G Klöppel
Journal:  Histopathology       Date:  1983-09       Impact factor: 5.087

10.  Surgical treatment for carcinoma of the pancreas. Experience in 272 patients.

Authors:  S Matsuno; T Sato
Journal:  Am J Surg       Date:  1986-11       Impact factor: 2.565

View more
  4 in total

1.  Prognostic value of histological grading in ductal adenocarcinoma of the pancreas. Klöppel vs TNM grading.

Authors:  P C Giulianotti; U Boggi; G Fornaciari; J Bruno; G Rossi; D Giardino; G Di Candio; F Mosca
Journal:  Int J Pancreatol       Date:  1995-06

2.  Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?

Authors:  S S Nitecki; M G Sarr; T V Colby; J A van Heerden
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

Review 3.  Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study.

Authors:  F J Prott; K Schönekaes; P Preusser; K Ostkamp; W Wagner; O Micke; R Pötter; U Sulkowski; C Rübe; T Berns; N Willich
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 4.  Pancreatic Cancer: 80 Years of Surgery-Percentage and Repetitions.

Authors:  Birgir Gudjonsson
Journal:  HPB Surg       Date:  2016-10-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.